Old Web
English
Sign In
Acemap
>
authorDetail
>
E. Groettrup-Wolfers
E. Groettrup-Wolfers
Bayer
Vilaprisan
Internal medicine
Medicine
Selective progesterone receptor modulator
Endocrinology
4
Papers
7
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Efficacy and safety of vilaprisan in women with uterine fibroids: Data from the phase 2b randomized controlled trial ASTEROID 2
2020
European Journal of Obstetrics & Gynecology and Reproductive Biology
Kristina Gemzell-Danielsson
Oskari Heikinheimo
János Zatik
Róbert Póka
Tomasz Rechberger
Robert Hudeček
Kathrin Petersdorf
Francisco Ramírez
T. Faustmann
E. Groettrup-Wolfers
Christian Seitz
Show All
Source
Cite
Save
Citations (5)
Efficacy and safety of the selective progesterone receptor modulator (PRM) vilaprisan: integrated analysis of phase 2 asteroid 1 and 2 studies
2018
Fertility and Sterility
K. Gemzell Danielsson
Linda D. Bradley
C. Ahlers
T. Faustmann
K. Petersdorf
Michal Zvolanek
E. Groettrup-Wolfers
Christian Seitz
Show All
Source
Cite
Save
Citations (2)
Efficacy and safety of the selective progesterone receptor modulator (PRM) vilaprisan: a sub-analysis of the asteroid 1 trial by ethnicity
2018
Fertility and Sterility
Linda D. Bradley
E. Groettrup-Wolfers
Michal Zvolanek
K. Petersdorf
Christian Seitz
Show All
Source
Cite
Save
Citations (0)
Efficacy and safety of the selective progesterone receptor modulator (PRM) vilaprisan - 24-week outcomes from asteroid 2
2018
Fertility and Sterility
K. Gemzell Danielsson
F. Ramirez
K. Petersdorf
T. Faustmann
E. Groettrup-Wolfers
Christian Seitz
Show All
Source
Cite
Save
Citations (0)
1